UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2012
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 000-10030
APPLE INC.
(Exact name of Registrant as specified in its charter)
California
94-2404110
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer Identification No.)
1 Infinite Loop
Cupertino, California
95014
(Address of principal executive offices)
(Zip Code)
Registrant s telephone number, including area code: (408) 996-1010
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes No
Indicate by check mark whether the registrant has submitted electronically
and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such files).
Yes No
Indicate by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
(Do not check if a smaller reporting company)
Smaller reporting company
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes No
935,062,000 shares of common stock issued and outstanding as of April 13,
2012
PART I. FINANCIAL INFORMATION
Item 1.
Financial Statements
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(in millions, except number of shares which are reflected in thousands and per share amounts)
September 30,
September 30,
September 30,
September 30,
Three Months Ended
Six Months Ended
March 31,
2012
March 26,
2011
March 31,
2012
March 26,
2011
Net sales
39,186
24,667
85,519
51,408
Cost of sales
20,622
14,449
46,252
30,892
Gross margin
18,564
10,218
39,267
20,516
Operating expenses:
Research and development
841
581
1,599
1,156
Selling, general and administrative
2,339
1,763
4,944
3,659
Total operating expenses
3,180
2,344
6,543
4,815
Operating income
15,384
7,874
32,724
15,701
Other income and expense
148
26
285
162
Income before provision for income taxes
15,532
7,900
33,009
15,863
Provision for income taxes
3,910
1,913
8,323
3,872
Net income
11,622
5,987
24,686
11,991
Earnings per common share:
Basic
12.45
6.49
26.48
13.02
Diluted
12.30
6.40
26.17
12.83
Shares used in computing earnings per share:
Basic
933,582
923,196
932,265
921,245
Diluted
944,893
935,944
943,185
934,549
See accompanying Notes to Condensed Consolidated Financial Statements.
APPLE INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(in millions, except number of shares which are reflected in thousands)
September 30,
September 30,
March 31,
2012
September 24,
2011
ASSETS:
Current assets:
Cash and cash equivalents
10,121
9,815
Short-term marketable securities
18,417
16,137
Accounts receivable, less allowances of $83 and $53, respectively
7,042
5,369
Inventories
1,102
776
Deferred tax assets
2,253
2,014
Vendor non-trade receivables
6,727
6,348
Other current assets
5,050
4,529
Total current assets
50,712
44,988
Long-term marketable securities
81,638
55,618
Property, plant and equipment, net
8,847
7,777
Goodwill
1,141
896
Acquired intangible assets, net
3,604
3,536
Other assets
4,992
3,556
Total assets
150,934
116,371
LIABILITIES AND SHAREHOLDERS EQUITY:
Current liabilities:
Accounts payable
17,011
14,632
Accrued expenses
9,778
9,247
Deferred revenue
5,247
4,091
Total current liabilities
32,036
27,970
Deferred revenue - non-current
2,446
1,686
Other non-current liabilities
13,954
10,100
Total liabilities
48,436
39,756
Commitments and contingencies
Shareholders equity:
Common stock, no par value; 1,800,000 shares authorized; 934,982 and 929,277 shares issued and outstanding,
respectively
14,850
13,331
Retained earnings
87,124
62,841
Accumulated other comprehensive income
524
443
Total shareholders equity
102,498
76,615
Total liabilities and shareholders equity
150,934
116,371
See accompanying Notes to Condensed Consolidated Financial Statements.
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(in millions)
September 30,
September 30,
Six Months Ended
March 31,
2012
March 26,
2011
Cash and cash equivalents, beginning of the period
9,815
11,261
Operating activities:
Net income
24,686
11,991
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation, amortization and accretion
1,461
790
Share-based compensation expense
844
586
Deferred income tax expense
2,915
1,563
Changes in operating assets and liabilities:
Accounts receivable, net
(1,663
(288
Inventories
(326
121
Vendor non-trade receivables
(379
(883
Other current and non-current assets
(1,510
(1,886
Accounts payable
2,809
1,626
Deferred revenue
1,916
698
Other current and non-current liabilities
778
1,674
Cash generated by operating activities
31,531
15,992
Investing activities:
Purchases of marketable securities
(85,022
(42,260
Proceeds from maturities of marketable securities
7,702
10,211
Proceeds from sales of marketable securities
49,052
21,705
Payments made in connection with business acquisitions, net of cash acquired
(350
Payments for acquisition of property, plant and equipment
(2,778
(1,838
Payments for acquisition of intangible assets
(160
(81
Other
(48
12
Cash used in investing activities
(31,604
(12,251
Financing activities:
Proceeds from issuance of common stock
377
494
Excess tax benefits from equity awards
636
740
Taxes paid related to net share settlement of equity awards
(634
(258
Cash generated by financing activities
379
976
Increase in cash and cash equivalents
306
4,717
Cash and cash equivalents, end of the period
10,121
15,978
Supplemental cash flow disclosure:
Cash paid for income taxes, net
4,835
1,913
See accompanying Notes to Condensed Consolidated Financial Statements.
Apple Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 Summary of Significant Accounting Policies
Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs,
manufactures, and markets mobile communication and media devices, personal computers, and portable digital music players, and sells a variety of related software, services, peripherals, networking solutions, and third-party digital content and
applications. The Company sells its products worldwide through its retail stores, online stores, and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the
Company sells a variety of third-party iPhone, iPad, Macintosh ( Mac ), and iPod compatible products including application software and various accessories through its online and retail stores. The Company sells to consumers, small and
mid-sized businesses, and education, enterprise and government customers.
Basis of Presentation and Preparation
The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions
have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and assumptions that affect the
amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Prior period costs associated with the Company s high-profile retail stores have been
reclassified to conform to the current period s presentation. Refer to Note 7, Segment Information and Geographic Data, of this Form 10-Q.
These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company s annual consolidated financial statements and the notes thereto for the fiscal
year ended September 24, 2011, included in its Annual Report on Form 10-K (the 2011 Form 10-K ). The Company s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. The Company s fiscal year
2012 will include 53-weeks and ends on September 29, 2012. An additional week has been included in the first quarter of 2012 to realign the Company s fiscal quarters more closely to calendar quarters. Unless otherwise stated, references to
particular years or quarters refer to the Company s fiscal years ended in September and the associated quarters of those fiscal years.
Earnings Per Common Share
Basic earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of shares
of common stock outstanding during the period. Diluted earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to
include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the
Company s employee stock purchase plan and unvested restricted stock units ( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per common share by application of the treasury stock method.
Under the treasury stock method, an increase in the fair market value of the Company s common stock can result in a greater dilutive effect from potentially dilutive securities.
The following table sets forth the computation of basic and diluted earnings per common
share for the three- and six-month periods ended March 31, 2012 and March 26, 2011 (in thousands, except net income in millions and per share amounts):
September 30,
September 30,
September 30,
September 30,
Three Months Ended
Six Months Ended
March 31,
2012
March 26,
2011
March 31,
2012
March 26,
2011
Numerator:
Net income
11,622
5,987
24,686
11,991
Denominator:
Weighted-average shares outstanding
933,582
923,196
932,265
921,245
Effect of dilutive securities
11,311
12,748
10,920
13,304
Weighted-average diluted shares
944,893
935,944
943,185
934,549
Basic earnings per common share
12.45
6.49
26.48
13.02
Diluted earnings per common share
12.30
6.40
26.17
12.83
The number of potentially dilutive securities excluded from the computation of diluted earnings per
common share because their effect would have been antidilutive was not significant for the three- and six-month periods ended March 31, 2012 and March 26, 2011.
Fair Value Measurements
Fair value is the price that would be received
from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value
into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:
Level 1 Quoted prices in active markets for identical assets or liabilities.
Level 2 Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets,
or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 Inputs that are generally unobservable and typically reflect management s estimate of assumptions that market participants would use in pricing the asset or liability.
Note 2 Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables show the Company s cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category
recorded as cash and cash equivalents or short-term or long-term marketable securities as of March 31, 2012 and September 24, 2011 (in millions):
September 30,
September 30,
September 30,
September 30,
September 30,
September 30,
September 30,
March 31, 2012
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
2,911
2,911
2,911
Level 1:
Money market funds
1,513
1,513
1,513
Mutual funds
1,255
(5
1,258
1,258
Subtotal
2,768
(5
2,771
1,513
1,258
Level 2:
U.S. Treasury securities
18,469
10
(17
18,462
1,278
3,831
13,353
U.S. agency securities
21,130
35
(8
21,157
1,827
2,781
16,549
Non-U.S. government securities
5,326
78
(4
5,400
1,661
3,739
Certificates of deposit and time deposits
2,885
2,887
986
339
1,562
Commercial paper
2,545
2,545
1,497
1,048
Corporate securities
43,391
307
(32
43,666
85
6,856
36,725
Municipal securities
4,792
53
(5
4,840
24
640
4,176
Mortgage and asset-backed securities
5,535
(5
5,537
5,534
Subtotal
104,073
492
(71
104,494
5,697
17,159
81,638
Total
109,752
500
(76
110,176
10,121
18,417
81,638
September 30,
September 30,
September 30,
September 30,
September 30,
September 30,
September 30,
September 24, 2011
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
2,903
2,903
2,903
Level 1:
Money market funds
1,911
1,911
1,911
Mutual funds
1,227
(34
1,193
1,193
Subtotal
3,138
(34
3,104
1,911
1,193
Level 2:
U.S. Treasury securities
10,717
39
(3
10,753
1,250
2,149
7,354
U.S. agency securities
13,467
24
(3
13,488
225
1,818
11,445
Non-U.S. government securities
5,559
11
(2
5,568
551
1,548
3,469
Certificates of deposit and time deposits
4,175
(2
4,175
728
977
2,470
Commercial paper
2,853
2,853
2,237
616
Corporate securities
35,241
132
(114
35,259
10
7,241
28,008
Municipal securities
3,411
56
3,467
595
2,872
Subtotal
75,423
264
(124
75,563
5,001
14,944
55,618
Total
81,464
264
(158
81,570
9,815
16,137
55,618
The net unrealized gains as of March 31, 2012 and September 24, 2011 are related primarily to
long-term marketable securities. The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The
Company recognized no significant net realized gains or losses during the three- and six-month periods ended March 31, 2012 and March 26, 2011 related to such sales. The maturities of the Company s long-term marketable securities
generally range from one to five years.
As of March 31, 2012 and September 24, 2011, gross unrealized losses
related to individual securities that had been in a continuous loss position for 12 months or longer were not significant.
The Company considers the declines in market value of its marketable securities investment portfolio to be temporary in nature. The
Company typically invests in highly-rated securities, and its policy generally limits the amount of credit exposure to any one issuer. The Company s investment policy requires investments to generally be investment grade, with the primary
objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating an investment for other-than-temporary impairment, the Company reviews factors such
as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, and the Company s intent to sell, or whether it is more likely than not it will be required to
sell the investment before recovery of the investment s cost basis. During the three- and six-month periods ended March 31, 2012 and March 26, 2011, the Company did not recognize any significant impairment charges. As of
March 31, 2012, the Company does not consider any of its investments to be other-than-temporarily impaired.
Derivative Financial
Instruments
The Company uses derivatives to partially offset its business exposure to foreign currency exchange risk. The
Company may enter into foreign currency forward and option contracts to offset some of the foreign exchange risk on expected future cash flows on certain forecasted revenue and cost of sales, on net investments in certain foreign subsidiaries, and
on certain existing assets and liabilities.
To help protect gross margins from fluctuations in foreign currency exchange rates, certain
of the Company s subsidiaries whose functional currency is the U.S. dollar hedge a portion of forecasted foreign currency revenue. The Company s subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies
may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases
generally up to six months.
To help protect the net investment in a foreign operation from adverse changes in foreign
currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates.
The Company may also enter into foreign currency forward and option contracts to partially offset the foreign currency exchange gains and
losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. However, the Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons including, but not
limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency
exchange rates.
The Company records all derivatives on the Condensed Consolidated Balance Sheets at fair value. The
Company s accounting policies for these instruments are based on whether the instruments are designated as hedge or non-hedge instruments. The effective portions of cash flow hedges are recorded in accumulated other comprehensive income
( AOCI ) until the hedged item is recognized in earnings. The effective portions of net investment hedges are recorded in other comprehensive income as a part of the cumulative translation adjustment. The ineffective portions of cash flow
hedges and net investment hedges are recorded in other income and expense. Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item the derivative relates to.
The Company had a net deferred gain associated with cash flow hedges of approximately $105 million and $290 million, net of
taxes, recorded in AOCI as of March 31, 2012 and September 24, 2011, respectively. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the
related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Substantially all of the
Company s hedged transactions as of March 31, 2012 are expected to occur within six months.
Derivative instruments
designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in
AOCI associated with such derivative instruments are reclassified immediately into other income and expense. Any subsequent changes in fair value of such derivative instruments are reflected in other income and expense unless they are re-designated
as hedges of other transactions. The Company did not recognize any significant net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during the three- and six-month periods ended March 31, 2012 and
March 26, 2011.
The Company s unrealized net gains and losses on net investment hedges, included in the cumulative
translation adjustment account of AOCI, were not significant as of March 31, 2012 and September 24, 2011, respectively. The ineffective portions and amounts excluded from the effectiveness test of net investment hedges are recorded in
other income and expense.
During the three and six months ended March 31, 2012 and March 26, 2011, the gain/loss
recognized in other income and expense for foreign currency forward and option contracts not designated as hedging instruments was not significant. These amounts represent the net gain or loss on the derivative contracts and do not include changes
in the related exposures, which generally offset a portion of the gain or loss on the derivative contracts.
The following table shows the notional principal amounts of the Company s outstanding
derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of March 31, 2012 and September 24, 2011 (in millions):
September 30,
September 30,
September 30,
September 30,
March 31, 2012
September 24, 2011
Notional
Principal
Credit Risk
Amounts
Notional
Principal
Credit Risk
Amounts
Instruments qualifying as accounting hedges:
Foreign exchange contracts
20,505
336
13,705
537
Instruments other than accounting hedges:
Foreign exchange contracts
13,585
43
9,891
56
The notional principal amounts for outstanding derivative instruments provide one measure of the
transaction volume outstanding and does not represent the amount of the Company s exposure to credit or market loss. The credit risk amounts represent the Company s gross exposure to potential accounting loss on derivative instruments that
are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency exchange rates at each respective date. The Company s gross exposure on these transactions may be
further mitigated by collateral received from certain counterparties. The Company s exposure to credit loss and market risk will vary over time as a function of currency exchange rates. Although the table above reflects the notional principal
and credit risk amounts of the Company s foreign exchange instruments, it does not reflect the gains or losses associated with the exposures and transactions that the foreign exchange instruments are intended to hedge. The amounts ultimately
realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.
The Company generally enters into master netting arrangements, which reduce credit risk by permitting net settlement of transactions with
the same counterparty. To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net fair value of certain financial instruments fluctuates from
contractually established thresholds. The Company presents its derivative assets and derivative liabilities at their gross fair values. The Company received cash collateral related to the derivative instruments under its collateral security
arrangements of $217 million and $288 million as of March 31, 2012 and September 24, 2011, respectively. These amounts are classified as accrued expenses in the Condensed Consolidated Balance Sheets. The Company did not have any derivative
instruments with credit risk-related contingent features that would require it to post additional collateral as of March 31, 2012 or September 24, 2011.
The following tables show the Company s derivative instruments measured at gross fair value as reflected in the Condensed Consolidated Balance Sheets as of March 31, 2012 and September 24,
2011 (in millions):
September 30,
September 30,
September 30,
March 31, 2012
Fair Value of
Derivatives
Designated
as Hedge
Instruments
Fair Value of
Derivatives
Not Designated
as Hedge
Instruments
Total
Fair
Value
Derivative assets (a):
Foreign exchange contracts
308
43
351
Derivative liabilities (b):
Foreign exchange contracts
129
27
156
10
September 30,
September 30,
September 30,
September 24, 2011
Fair Value of
Derivatives
Designated
as Hedge
Instruments
Fair Value of
Derivatives
Not Designated
as
Hedge
Instruments
Total
Fair
Value
Derivative assets (a):
Foreign exchange contracts
460
56
516
Derivative liabilities (b):
Foreign exchange contracts
72
37
109
(a)
The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed
Consolidated Balance Sheets.
(b)
The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed